Table 3 Clinical characteristics of study participants
Clinical information | Frequency | Percent |
|---|---|---|
Patient regimen at the time of taking last viral load | n = 68 | |
AZT/3TC/NVP | 15 | 12.3 |
TDF/3TC/EFV | 50 | 41.0 |
TDF/3TC/NVP | 2 | 1.6 |
AZT/3TC/EFV | 1 | 0.8 |
Received adherence counseling before ART | n = 122 | |
Yes | 101 | 82.8 |
No | 21 | 17.2 |
Recorded adherence on the chart at the time of taking the viral load | n = 55 | |
Good | 43 | 78.2 |
Poor | 12 | 21.8 |
Missed appointments in the last 1 year | n = 122 | |
Yes | 65 | 53.7 |
No | 57 | 46.3 |
Clinical failure in the last 12 months | n = 54 | |
Yes | 5 | 9.3 |
No | 49 | 90.7 |
Immunological failure | n = 54 | |
Yes | 23 | 42.6 |
No | 31 | 57.4 |
Duration on ART | n = 122 | |
Less than 3 years | 40 | 32.8 |
3–5 years | 39 | 32.0 |
More than 5 years | 43 | 35.2 |